Abstract: Examples described herein include systems, methods, instructions, and other implementations for data security with integrated installment payment systems. In one example, account security system receives a checkout communication that includes data describing a validated checkout system of a merchant system. A client token is transmitted in response to an authentication that the checkout communication is from the validated checkout system, and an account communication including the client token and secure client information is received from a client device. An installment payment communication associated with the secure transaction is received from a system other than a merchant system involved in the transaction. The secure transaction is then facilitated following receipt of the installment payment communication.

Abstract: Disclosed herein is a method and apparatus for observing a manufacturing line, wherein the manufacturing line includes at least one robotic element for moving at least one part, the method comprising receiving, at a processor separate from the manufacturing line, sensor data about the at least one robotic element, and when the sensor data exceeds a boundary condition, triggering a feed-back collection event. The feed-back collection event includes identifying a stream of sensor data, capturing feed-back data at a data collection device associated with the at least one robotic element, tagging the feed-back data to reflect the at least one part associated with the boundary condition, identifying, within the feed-back data, when the boundary condition is exceeded by the at least one part in real time, and storing the feed-back data relating to the boundary condition in association with the sensor data and the boundary condition.

Abstract: A system and method for treating critical limb ischemia (CLI) including a radiopaque micro stent disposed for cross ankle stenting as well as retrograde pedal/tibial artery access, in conjunction with antegrade access for the recanalization of impaired tibial vessels. A radiopaque medical device is constructed from a tubular-shaped body having a thin wall defining a specific strut pattern. In an additional aspect, the present apparatus introduces a new radiopaque medical device, such as a stent, wherein the tubular body includes a super elastic, nickel-titanium (nitinol) alloy.

Abstract: Systems, methods and accompanying apparatuses to treat critical limb ischemia through the superficial femoral arteries utilizing a specifically designed delivery package for entry proximal to area above the ankle with the capability to antegrade access via PT or AT into ankle and foot and retrograde access via pedal or plantar arch into the dorsalis pedis artery (DP).

Abstract: A stent delivery system, which includes a catheter and a stent stabilizer and pusher mechanism to capture and deploy a braided stent. The stabilizer pusher mechanism has a reinforced polymer shaft with two ends, a hub, a marker band and a braided mesh sock. The stent stabilizer and pusher mechanism further possesses a reinforced polymer shaft, which is constructed to have a low friction lumen. The low friction lumen may be guide wire compatible.

Abstract: A system and accompanying methods for treating a blockage of the superior femoral artery including utilization of a puncture insertion mechanism, an introducer sheath, a guide catheter and an expandable device. Entry into the body is established through the popliteal and advancing retrograde through the popliteal artery toward the lower superior femoral artery region and in some embodiments utilizing an introducer sheath, a guide catheter and a balloon are featured.

Abstract: A medical device such as a catheter may have an elongate shaft that includes a hypotube having a cut formed therein. The elongate shaft may define a lumen that extends within the elongate shaft. A polymer may be disposed over at least a portion of the hypotube. A medical device may include a cut hypotube having a constant pitch and may be configured to reversibly and temporarily alter the pitch of at least a portion of the cut hypotube. In some cases, the medical device may be configured to reversibly and/or temporarily alter a compressive strength of at least a portion of the cut hypotube.

Abstract: The present invention is directed to a pharmaceutical composition that includes a combination of about 2-5 milligrams of a non-steroidal anti-inflammatory drug and from about 2-30 milligrams of an opioid analgesic in a single pharmaceutical dosage unit that can provide effective chronic pain management with the added benefit of reduced side effects such as withdrawal and gastrointestinal disorders. The non-steroidal anti-inflammatory drug may be piroxicam and the opioid analgesic may be buprenorphine. The present invention also provides for a method of managing pain in a patient that includes administering the pharmaceutical composition previously described. The pharmaceutical composition previously described may be administered in a single or multiple dosage regimen.

Abstract: The present invention is directed to a pharmaceutical composition that includes a combination of about 2-5 milligrams of a non-steroidal anti-inflammatory drug and from about 2-30 milligrams of an opioid analgesic in a single pharmaceutical dosage unit that can provide effective chronic pain management with the added benefit of reduced side effects such as withdrawal and gastrointestinal disorders. The non-steroidal anti-inflammatory drug may be piroxicam and the opioid analgesic may be buprenorphine. The present invention also provides for a method of managing pain in a patient that includes administering the pharmaceutical composition previously described. The pharmaceutical composition previously described may be administered in a single or multiple dosage regimen.

Abstract: The present invention is directed to a pharmaceutical composition that includes a combination of about 2-5 milligrams of a non-steroidal anti-inflammatory drug and from about 2-30 milligrams of an opioid analgesic in a single pharmaceutical dosage unit that can provide effective chronic pain management with the added benefit of reduced side effects such as withdrawal and gastrointestinal disorders. The non-steroidal anti-inflammatory drug may be piroxicam and the opioid analgesic may be buprenorphine. The present invention also provides for a method of managing pain in a patient that includes administering the pharmaceutical composition previously described. The pharmaceutical composition previously described may be administered in a single or multiple dosage regimens.

Abstract: The system and method for protecting multiple networked enclaves each having one or more insecure machines. The system may include an attack detector as part of a secure node (e.g., SAFE node) proxy. The system may include an attack detector external to the proxy. The proxy may support multiple detectors and its actions may include isolating an insecure machine, cleansing an insecure machine, or tattling on (impugning the reputation of) an insecure machine.

Abstract: A coil-reinforced medical device delivery mechanism including a stiff proximal end for enhanced pushability and a soft distal end, including a free floating tip portion, for increased maneuverability and decreased breakage. The system utilizes a non-compliant balloon mounted on a flexible, single lumen shaft device with a support mandrel construction.

Abstract: A stent delivery system, which includes a catheter and a stent stabilizer and pusher mechanism to capture and deploy a braided stent. The stabilizer pusher mechanism has a reinforced polymer shaft with two ends, a hub, a marker band and a braided mesh sock. The stent stabilizer and pusher mechanism further possesses a reinforced polymer shaft, which is constructed to have a low friction lumen. The low friction lumen may be guide wire compatible.

Abstract: A system and method for treating critical limb ischemia (CLI) including a radiopaque micro stent disposed for cross ankle stenting as well as retrograde pedal/tibial artery access, in conjunction with antegrade access for the recanalization of impaired tibial vessels. A radiopaque medical device is constructed from a tubular-shaped body having a thin wall defining a specific strut pattern. In an additional aspect, the present apparatus introduces a new radiopaque medical device, such as a stent, wherein the tubular body includes a super elastic, nickel-titanium (nitinol) alloy.

Abstract: A medical device such as a catheter may have an elongate shaft that includes a hypotube having a cut formed therein. The elongate shaft may define a lumen that extends within the elongate shaft. A polymer may be disposed over at least a portion of the hypotube. A medical device may include a cut hypotube having a constant pitch and may be configured to reversibly and temporarily alter the pitch of at least a portion of the cut hypotube. In some cases, the medical device may be configured to reversibly and/or temporarily alter a compressive strength of at least a portion of the cut hypotube.

Abstract: The system and method for protecting multiple networked enclaves each having one or more insecure machines. The system may include an attack detector as part of a secure node (e.g., SAFE node) proxy. The system may include an attack detector external to the proxy. The proxy may support multiple detectors and its actions may include isolating an insecure machine, cleansing an insecure machine, or tattling on (impugning the reputation of) an insecure machine.

Abstract: The present invention provides a method of determining whether a subject is afflicted with a depressive disorder comprising: (i) introducing into the subject a positron emission tomography (PET) radioligand capable of binding with a serotonin 5-HT1A receptor; (ii) performing one or more PET scans of the subject; (iii) determining, by analysis of the one or more PET images, a receptor binding potential of the PET radioligand for the serotonin 5-HT1A receptor in a region of interest in the subject; (iv) comparing the receptor binding potential value of the PET radioligand in the region of interest in the subject to a predetermined receptor binding potential threshold value; and (v) classifying the subject as having the depressive disorder or as not having the depressive disorder based on the comparison of step (iv), thereby determining whether the subject is afflicted with the depressive disorder.

Abstract: A coil-reinforced medical device delivery mechanism including a stiff proximal end for enhanced pushability and a soft distal end, including a free floating tip portion, for increased maneuverability and decreased breakage. The system utilizes a non-compliant balloon mounted on a flexible, single lumen shaft device with a support mandrel construction.

Abstract: In some embodiments, the present invention may be directed to various pharmaceutical dosage units comprising at least one opioid analgesic in combination with a benzodiazepine blocker. In some embodiments, the present invention may be directed to various methods of treatment using such pharmaceutical dosage units. In some embodiments, these pharmaceutical dosage units may be used for treating: pain, chronic pain, sub-acute pain, chronic and sub-acute pain, anxiety, addiction in general, opiate addiction, and benzodiazepine addiction, opiate and benzodiazepine addiction; opiate dependence, benzodiazepine dependence; and for reducing a likelihood of overdose associated with concomitant use of opiates with benzodiazepines, and for mitigating against drug diversion.

Abstract: A filtration system to collect debris in the vascular system and/or other systems and a method for using such filter. An internally disposed apparatus for inside a fluid conduit during a medical procedure which includes a filtering membrane and a frame connected to the membrane. In one embodiment of the filtration system, a filter may generally include a membrane, a frame, and a rod.